SFCM
PMVP icon

Seven Fleet Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Seven Fleet Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.7K Hold
63,498
– – 0.02% 113
2025
Q4 		$79.4K Buy
+63,498
New +$85.1K 0.05% 75

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Seven Fleet Capital Management's PMVP Position: Q1 2026 in Review

Seven Fleet Capital Management held its PMV Pharmaceuticals (PMVP) position steady in Q1 2026 at 63,498 shares worth $78.7K. The position accounts for 0.02% of the portfolio, ranked #113.

Seven Fleet Capital Management first reported a position in PMVP in Q4 2025 and has held it in 2 quarters since. The position peaked at $79.4K in Q4 2025. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Seven Fleet Capital Management held 63,498 shares of PMV Pharmaceuticals worth $78.7K as of Q1 2026.
  • Seven Fleet Capital Management left its PMV Pharmaceuticals share count unchanged in Q1 2026.
  • PMV Pharmaceuticals made up 0.02% of Seven Fleet Capital Management's portfolio in Q1 2026, its #113 holding.
  • Seven Fleet Capital Management first reported a position in PMV Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's PMV Pharmaceuticals position peaked at $79.4K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.